CardioGard received a 510(K) clearance for its Emboli Protection Cannula


We are pleased to announce that CardioGard, a Peregrine Ventures portfolio company, has received a 510(K) clearance for its Emboli protection cannula, and the device can now be imported into and marketed in the United States.

CardioGard is developing a specially designed arterial (aortic) cannula for use in cardiac surgery for the purpose of removal of gaseous and solid embolic material emanating from aortic manipulations. The cannula comprises a double lumen where the primary lumen provides oxygenated blood from the heart-lung machine to the patient and a secondary lumen suctions blood and embolic matter away from the surgical field and back to the cardiopulmonary bypass machine for filtration.

Recent Posts
Featured Posts
Follow Us
Search By Tags
Archive
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Contact Info

6 Yoni Netanyahu Street
Or Yehuda, 60376, Israel

Phone: +972 -3- 634 9990 
Fax: +972 -3- 634 9910

 

Map & Directions >>

Portfolio

Life Sciences

Software

 

 

© Peregrine Ventures  |  Terms & Conditions  |  Privacy Policy